Cardiac surgery in the heart transplant recipient: Outcome analysis and long-term results

Area of Science:

• Cardiology
• Cardiac Surgery
• Transplantation Medicine

Background:

• Improved survival rates in cardiac transplantation are leading to increased use of extended donor criteria.
• This shift necessitates managing a growing number of patients at risk for cardiac pathology requiring surgical intervention.
• Understanding outcomes of reoperation in this population is crucial.

Purpose of the Study:

• To analyze the outcomes of patients requiring subsequent cardiac surgery after heart transplantation.
• To identify the primary indications for reoperation and assess associated mortality and morbidity.

Main Methods:

• Retrospective analysis of 479 heart transplant recipients at University Hospital Heidelberg (1991-2010).
• Identified 18 patients (3.8%) who underwent reoperation by 2018.
• Evaluated indications, early mortality, and long-term survival rates.

Main Results:

• Valvular disease, particularly tricuspid valve pathology (10/16 cases), was the main indication for reoperation.
• Coronary artery bypass grafting (CABG) and re-transplantation were less common indications.
• Early mortality was 11.1%; 1, 5, and 10-year survival rates were 88.1%, 81.4%, and 52.2%, respectively.

Conclusions:

• Redo cardiac surgery in heart transplant recipients can be performed with acceptable mortality and morbidity.
• Atrioventricular valve pathology is a significant driver for reoperation in this cohort.
• These findings support the feasibility of surgical correction for post-transplant cardiac complications.